What is the address of MILHO-Clinics?

The registered office of MILHO-Clinics is located at Vlierstraat 30, 8400 Oostende.

Is MILHO-Clinics still active?

Yes. According to the CBE (2 November 2026) MILHO-Clinics is active, legal situation “Normale toestand”, started on 6 December 2012.

Is MILHO-Clinics registered on Peppol?

Yes, MILHO-Clinics is registered on the Peppol network with ID 0208:0501805150.

What is the enterprise number of MILHO-Clinics?

The enterprise number of MILHO-Clinics is BE0501805150.

When was MILHO-Clinics founded?

MILHO-Clinics was founded on 6 December 2012.

Who are the directors of MILHO-Clinics?

According to the 2025 annual accounts, the directors of MILHO-Clinics are: Stefaan Reynders.

Is MILHO-Clinics a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 December 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MILHO-Clinics make in 2025?

MILHO-Clinics posted a profit after taxes of € 50,543 in financial year 2025.

What is the revenue of MILHO-Clinics?

As a small company, MILHO-Clinics is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 76,960.

MILHO-Clinics (Private Limited) - Oostende - BE0501805150

Dossier MILHO-Clinics, printed on 2 November 2026 from databakkes.be/en/0501805150/milho-clinics. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MILHO-Clinics from Oostende, company number BE0501805150, closed financial year 2025 with a result of € 50,543 after tax. For that financial year MILHO-Clinics recorded a gross margin of € 76,960 and equity of € 970,505. Compared with financial year 2024, the result moved from € 62,489 to € 50,543. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Healthy

€ 970,505

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 50,543

▼ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 321,336

▲ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 92,292 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

€ 8,511

▼ 80% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 2,548

▲ 35% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 37,230

▲ 56% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 412,565 Gross margin 2022: € 412,565 First fiscal year in the series	€ 371,747 Gross margin 2023: € 371,747 ▼ 10% vs 2022 (€ 412,565) Unfavourable step	€ 119,759 Gross margin 2024: € 119,759 ▼ 68% vs 2023 (€ 371,747) Unfavourable step	€ 76,960 Gross margin 2025: € 76,960 ▼ 36% vs 2024 (€ 119,759) Unfavourable step	▼ 36%
Profit after taxes	€ 247,668 Profit after taxes 2022: € 247,668 First fiscal year in the series	€ 274,065 Profit after taxes 2023: € 274,065 ▲ 11% vs 2022 (€ 247,668) Favourable step	€ 62,489 Profit after taxes 2024: € 62,489 ▼ 77% vs 2023 (€ 274,065) Unfavourable step	€ 50,543 Profit after taxes 2025: € 50,543 ▼ 19% vs 2024 (€ 62,489) Unfavourable step	▼ 19%
Equity	€ 1,284,393 Equity 2022: € 1,284,393 First fiscal year in the series	€ 949,766 Equity 2023: € 949,766 ▼ 26% vs 2022 (€ 1,284,393) Unfavourable step	€ 1,012,255 Equity 2024: € 1,012,255 ▲ 7% vs 2023 (€ 949,766) Favourable step	€ 970,505 Equity 2025: € 970,505 ▼ 4% vs 2024 (€ 1,012,255) Unfavourable step	▼ 4%
Total debts	€ 159,525 Total debts 2022: € 159,525 First fiscal year in the series	€ 676,370 Total debts 2023: € 676,370 ▲ € 516,845 vs 2022 (€ 159,525) Unfavourable step	€ 68,327 Total debts 2024: € 68,327 ▼ 90% vs 2023 (€ 676,370) Favourable step	€ 135,513 Total debts 2025: € 135,513 ▲ 98% vs 2024 (€ 68,327) Unfavourable step	▲ 98%
Cash	€ 336,459 Cash 2022: € 336,459 First fiscal year in the series	€ 654,035 Cash 2023: € 654,035 ▲ 94% vs 2022 (€ 336,459) Favourable step	€ 280,854 Cash 2024: € 280,854 ▼ 57% vs 2023 (€ 654,035) Unfavourable step	€ 321,336 Cash 2025: € 321,336 ▲ 14% vs 2024 (€ 280,854) Favourable step	▲ 14%
Land & buildings	€ 376,730 Land & buildings 2022: € 376,730 First fiscal year in the series	€ 346,897 Land & buildings 2023: € 346,897 ▼ 8% vs 2022 (€ 376,730) Unchanged	€ 317,065 Land & buildings 2024: € 317,065 ▼ 9% vs 2023 (€ 346,897) Unchanged	€ 287,467 Land & buildings 2025: € 287,467 ▼ 9% vs 2024 (€ 317,065) Unchanged	▼ 9%
Retained profit	€ 1,264,393 Retained profit 2022: € 1,264,393 First fiscal year in the series	€ 936,155 Retained profit 2023: € 936,155 ▼ 26% vs 2022 (€ 1,264,393) Unfavourable step	€ 998,644 Retained profit 2024: € 998,644 ▲ 7% vs 2023 (€ 936,155) Favourable step	€ 956,894 Retained profit 2025: € 956,894 ▼ 4% vs 2024 (€ 998,644) Unfavourable step	▼ 4%
Dividend	€ 92,951 Dividend 2022: € 92,951 First fiscal year in the series	€ 160,456 Dividend 2023: € 160,456 ▲ 73% vs 2022 (€ 92,951) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 160,456) Unchanged	€ 92,292 Dividend 2025: € 92,292 Unchanged (€ 0) Unchanged
Bank debt	€ 110,787 Bank debt 2022: € 110,787 First fiscal year in the series	€ 76,695 Bank debt 2023: € 76,695 ▼ 31% vs 2022 (€ 110,787) Favourable step	€ 42,603 Bank debt 2024: € 42,603 ▼ 44% vs 2023 (€ 76,695) Favourable step	€ 8,511 Bank debt 2025: € 8,511 ▼ 80% vs 2024 (€ 42,603) Favourable step	▼ 80%
Balance sheet total	€ 1,443,918 Balance sheet total 2022: € 1,443,918 First fiscal year in the series	€ 1,626,136 Balance sheet total 2023: € 1,626,136 ▲ 13% vs 2022 (€ 1,443,918) Unchanged	€ 1,080,582 Balance sheet total 2024: € 1,080,582 ▼ 34% vs 2023 (€ 1,626,136) Unchanged	€ 1,106,018 Balance sheet total 2025: € 1,106,018 ▲ 2% vs 2024 (€ 1,080,582) Unchanged	▲ 2%

Key figures of MILHO-Clinics, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MILHO-Clinics?

What happened at MILHO-Clinics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 50,543 (▼ 19% vs 2024). Source: NBB ↗
Jan 1, 2013 New establishment in Oostende. KBO
Dec 6, 2012 Start of the company according to the CBE. KBO

In short

From € 247,668 profit in 2022 to € 50,543 profit in 2025.

Paid € 258,683 in corporate taxes since 2022.

Best year ever: 2023, with € 274,065 profit.

Paid out € 345,699 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Stefaan Reynders

MILHO-Clinics

Luce Care

HET NIEUWE TROJE

Oogcentrum Westkust

Behind MILHO-Clinics is Stefaan Reynders. Stefaan Reynders is also behind Luce Care, HET NIEUWE TROJE, Oogcentrum Westkust and Francis Vere.

Directors

According to the 2025 annual accounts

Stefaan Reynders

Manager

Also active at: Luce Care, HET NIEUWE TROJE, Oogcentrum Westkust, Francis Vere

Establishments

Establishment units

Physical locations of this company

Registered office

Vlierstraat 30

8400 Oostende

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0501.805.150
VAT number: BE 0501.805.150
Registered office: Vlierstraat 30, 8400 Oostende
Names & denominations: MILHO-Clinics
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 December 2012
Peppol: Active · Active since 14 Mar 2024

View on CBE Public ↗ Annual accounts (NBB) ↗